Skip to main content
Top
Published in: Clinical and Experimental Nephrology 6/2018

01-12-2018 | Original article

Dipstick proteinuria and all-cause mortality among the general population

Authors: Kunitoshi Iseki, Tsuneo Konta, Koichi Asahi, Kunihiro Yamagata, Shouichi Fujimoto, Kazuhiko Tsuruya, Ichiei Narita, Masato Kasahara, Yugo Shibagaki, Toshiki Moriyama, Masahide Kondo, Chiho Iseki, Tsuyoshi Watanabe

Published in: Clinical and Experimental Nephrology | Issue 6/2018

Login to get access

Abstract

Background

Dipstick proteinuria, but not albuminuria, is used for general health screening in Japan. How the results of dipstick proteinuria tests correlate with mortality and, however, is not known.

Methods

Subjects were participants of the 2008 Tokutei-Kenshin (Specific Health Check and Guidance program) in six districts in Japan. On the basis of the national database of death certificates from 2008 to 2012, we used a personal identifier in two computer registries to identify participants who might have died. The hazard ratio (95% confidence interval, CI) was calculated by Cox-proportional hazard analysis.

Results

Among a total of 140,761 subjects, we identified 1641 mortalities that occurred by the end of 2012. The crude mortality rates were 1.1% for subjects who were proteinuria (−), 1.5% for those with proteinuria (+/−), 2.0% for those with proteinuria (1+), 3.5% for those with proteinuria (2+), and 3.7% for those with proteinuria (≥ 3+). After adjusting for sex, age, body mass index, estimated glomerular filtration rate, comorbid condition, past history, and lifestyle, the hazard ratio (95% CI) for dipstick proteinuria was 1.262 (1.079–1.467) for those with proteinuria (+/−), 1.437 (1.168–1.748) for those with proteinuria (1+), 2.201 (1.688–2.867) for those with proteinuria (2+), and 2.222 (1.418–3.301) for those with proteinuria (≥ 3+) compared with the reference of proteinuria (−).

Conclusion

Dipstick proteinuria is an independent predictor of death among Japanese community-based screening participants.

Literature
  1. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010;303:423–9.View Article
  2. Yu TY, Li HY, Jiang YD, Chang TJ, Wei JN, Chuang LM. Proteinuria predicts 10-year cancer-related mortality in patients with type 2 diabetes. J Diabetes Complic. 2013;27:201–7.View Article
  3. Mok Y, Matsushita K, Sang Y, Ballew SH, Grams M, Shin SY, et al. Association of kidney disease measures with cause-specific mortality: the Korean Heart Study. PLoS One. 2016;11:e0153429.View Article
  4. Wang J, Li J, Wang A, Yang Y, Chen S, Wu S, et al. Dipstick proteinuria and risk of myocardial infarction and all-cause mortality in diabetes or pre-diabetes: a population-based cohort study. Sci Rep. 2017;7:11986.View Article
  5. Wen CP, Cheng TYD, Tsai MK, Chang YC, Chan HT, Tsai SP, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462293 adults in Taiwan. Lancet. 2008;371:2173–82.View Article
  6. Tanihara S, Hayakawa T, Oki I, Nakamura Y, Sakata K, Okayama A, et al. Proteinuria is a prognostic marker for cardiovascular mortality: NIPPON DATA 80, 1980–1999. J Epidemiol. 2005;15:146–53.View Article
  7. Nagata M, Ninomiya T, Kiyohara Y, Murakami Y, Irie F, Sairenchi T, et al. Prediction of cardiovascular disease mortality by proteinuria and reduced kidney function: pooled analysis of 39,000 individuals from 7 cohort studies in Japan. Am J Epidemiol. 2013;178:1–11.View Article
  8. Sato H, Konta T, Ichikawa K, Suzuki N, Kabasawa A, Suzuki K, et al. Comparison of the predictive ability of albuminuria and dipstick proteinuria for mortality in the Japanese population: the Yamagata (Takahata) study. Clin Exp Nephrol. 2016;20:611–7.View Article
  9. Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z, et al. Trends in chronic kidney disease in China. N Engl J Med. 2016;375:905–6.View Article
  10. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–100.View Article
  11. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17–28.View Article
  12. Weng PH, Hung KY, Huang HL, Chen JH, Sung PK, Huang KC. Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol. 2011;6:1121–8.View Article
  13. Goodkin DA, Young EW, Kurokawa K, Prütz KG, Levin NW. Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am J Kidney Dis. 2004;44(5 Suppl 2):16–21.View Article
  14. Iseki K, Asahi K, Moriyama T, Yamagata K, Tsuruya K, Yoshida H, et al. Risk factor profiles based on estimated glomerular filtration rate and dipstick proteinuria among participants of the Specific Health Check and Guidance System in Japan 2008. Clin Exp Nephrol. 2012;16:244–9.View Article
  15. Iseki K, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, et al. Mortality risk among screened subjects of the Specific Health Check and Guidance Program in Japan 2008–2012. Clin Exp Nephrol. 2017;21(6):978–85.View Article
  16. Iseki K, Konta T, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, et al. Association of dipstick hematuria with all-cause mortality in the general population: results from the Specific Health Check and Guidance Program in Japan. Nephrol Dial Transpl. 2017. https://​doi.​org/​10.​1093/​ndt/​gfx213.View Article
  17. Iseki K, Konta T, Asahi K, et al. Glucosuria is associated with a higher risk of all-cause mortality in both diabetes mellitus and non diabetes mellitus subjects among a general screening cohort. Clin Exp Nephrol. 2018. https://​doi.​org/​10.​1007/​s10157-017-1528-0.View ArticlePubMedPubMed Central
  18. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073–81.View Article
  19. Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality: a meta-analysis from the CKD Prognosis Consortium. JAMA. 2014;311:2518–31.View Article
  20. Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63:1468–74.View Article
  21. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama Study. Hypertension. 2006;47:149–54.View Article
  22. Matsushita K. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality: a collaborative meta-analysis of general population cohorts. Lancet. 2010;375(9731):2073–81.View Article
  23. Wang G, Staplin N, Emberson J, Baigen C, Turner R, Chalmers J, et al. Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies. BMC Cancer. 2016;16:488.View Article
  24. Hoogeveen EK, Geleijnse JM, Giltay EJ, Soedamah-Muth SS, de Goede J, Oude Griep LM, et al. Kidney function and specific mortality in 60–80 years old post-myocardial infarction patients: a 10-year follow-up study. PLos One. 2017;12(2):e0171868.View Article
  25. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.View Article
  26. Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and the diagnostic standard for metabolic syndrome. Nihon Naika Gakkai Zasshi 2005;94:794–809 (Japanese).View Article
  27. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, et al. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig. 2012;3:39–40.View Article
  28. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.View Article
  29. Lowrance WT, Ordoñez J, Udaltsova N, Russo P, Go AS. CKD and the risk of incident cancer. J Am Soc Nephrol. 2014;25:2327–34.View Article
  30. Jørgensen L, Heuch I, Jenssen T, Jacobsen BK. Association of albuminuria and cancer incidence. J Am Soc Nephrol. 2008;19:992–8.View Article
  31. Kondo M, Yamagata K, Hoshi SL, Saito C, Asahi K, Moriyama T, et al. Budget impact analysiof chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2014;18:885–91.View Article
  32. de Jager DJ, Vervloet MG, Dekker FW. Noncardiovascular mortality in CKD: an epidemiological perspective. Nat Rev Nephrol. 2014;10:208–14.View Article
  33. Konta T, Hao Z, Takasaki S, Abiko H, Ishikawa M, Takahashi T, et al. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol. 2007;11:51–5.View Article
  34. Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, Hamano T, et al. An overview of regular dialysis treatment in Japan (As of December 2013). Ther Apher Dial. 2015;19:540–74.View Article
  35. Iseki K, Ikemiya Y, Fukiyama K. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int. 1997;51:850–4.View Article
  36. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012;307:1941–51.View Article
  37. Imai E, Yamagata K, Iseki K, Iso H, Horio M, Makino H, et al. Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2:1360–6.View Article
  38. Nagai K, Sairenchi T, Irie F, Watanabe H, Ota H, Yamagata K. Relationship between estimated glomerular filtration rate and cardiovascular mortality in a Japanese cohort with long-term follow-up. PLoS One. 2016;11:e0156792.View Article
  39. Tanaka K, Watanabe T, Takeuchi A, Ohashi Y, Nitta K, Akizawa T, et al. Cardiovascular events and death in Japanese patients with chronic kidney disease. Kidney Int. 2017;91:227–34.View Article
  40. Konta T, Ichikawa K, Ikeda A, Fujimoto S, Iseki K, Moriyama T, et al. Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort. Am J Hypertens. 2012;25:342–7.View Article
  41. Yano Y, Sato Y, Fujimoto S, Konta T, Iseki K, Moriyama T, et al. Association of high pulse pressure with proteinuria in subjects with diabetes, pre-diabetes or normal glucose tolerance in a large Japanese general population sample. Diabetes Care. 2012;35:1310–5.View Article
  42. Yano Y, Fujimoto S, Kramer H, Sato Y, Konta T, Iseki K, et al. Long-term blood pressure variability, new-onset diabetes, and new-onset chronic kidney disease in the Japanese general population. Hypertension. 2015;66:30–6.View Article
  43. Tsuruya K, Yoshida H, Nagata M, Kitazono T, Iseki K, Iseki C, et al. Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of chronic kidney disease: a longitudinal study in a large Japanese population. Am J Kidney Dis. 2015;66:972–83.View Article
  44. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870–6.View Article
  45. Kovesdy CP, Coresh J, Ballew SH, Woodward M, Levin A, Naimark DM, et al. Past decline versus current eGFR and subsequent ESRD risk. J Am Soc Nephrol. 2015;27:2447–55.View Article
  46. Carrero JJ, Grams ME, Sang Y, Ärnlöv J, Gasparini A, Matsushita K, et al. Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality. Kidney Int. 2017;91:244–51.View Article
  47. Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA. 2012;308:2349–60.View Article
  48. Wakasugi M, Kazama JJ, Narita I, Iseki K, Fujimoto S, Moriyama T, et al. Association between overall lifestyle changes and the incidence of proteinuria: a population-based, cohort study. Intern Med. 2017;56(12):1475–84.View Article
  49. Yamagata K, Makino H, Iseki K, Ito S, Kimura K, Kusano E, et al. Effects of behaviour modification on outcome in early- to moderate-stage chronic kidney disease: a cluster-randomized trial. PLoS One. 2016;11:e0151422.View Article
  50. Hallan SI, Øvrehus MA, Romundstad S, Rifkin D, Langhammer A, Stevens PE, et al. Long-term trends with prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway. Kidney Int. 2016;90:665–73.View Article
  51. Jha V, Arici M, Collins AJ, Garcia-Garcia G, Hemmelgarn BR, Jafar TH, et al. Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney Int. 2016;90:1164–74.View Article
  52. Perkovic V, Agarwal R, Fioretto P, Hemmelgarn BR, Levin A, Thomas MC, et al. Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney Int. 2016;90:1175–83.View Article
  53. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA. 2003;290:3101–14.View Article
  54. Gansevoort RT, de Jong PE, Postma MJ. Cost-effectiveness of screening for proteinuria. JAMA. 2004;291:1442–3.PubMed
Metadata
Title
Dipstick proteinuria and all-cause mortality among the general population
Authors
Kunitoshi Iseki
Tsuneo Konta
Koichi Asahi
Kunihiro Yamagata
Shouichi Fujimoto
Kazuhiko Tsuruya
Ichiei Narita
Masato Kasahara
Yugo Shibagaki
Toshiki Moriyama
Masahide Kondo
Chiho Iseki
Tsuyoshi Watanabe
Publication date
01-12-2018
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 6/2018
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-1587-x

Other articles of this Issue 6/2018

Clinical and Experimental Nephrology 6/2018 Go to the issue

Acknowledgment

List of referees